On-demand electrochemically controlled compound release from an ultrasonically powered implant

7Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

On-demand drug delivery systems are promising for a wide range of therapeutic applications. When combined with wireless implants for controlled drug delivery, they can reduce overall dosage and side effects. Here, we demonstrate release of fluorescein from a novel on-demand release system for negatively charged compounds. The release system is based on a modified electroresponsive polypyrrole nanoparticulate film designed to minimize ion exchange with the stored compound - a major passive leakage mechanism. We further designed an ultrasonically powered mm-sized implant to electronically control the on-demand drug delivery system in vivo. Release kinetics are characterized both in vitro and in vivo in mice using fluorescein as a model drug, demonstrating the feasibility of wireless, controllable drug release using an ultrasonically powered implant.

Cite

CITATION STYLE

APA

Wang, M. L., Chamberlayne, C. F., Xu, H., Mofidfar, M., Baltsavias, S., Annes, J. P., … Arbabian, A. (2022). On-demand electrochemically controlled compound release from an ultrasonically powered implant. RSC Advances, 12(36), 23337–23345. https://doi.org/10.1039/d2ra03422k

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free